- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Tilray Inc(TLRY)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for TLRY
11/13/2026: TLRY (1-star) is currently NOT-A-BUY. Pass it for now.
Tilray Brands is a global consumer goods and cannabis company operating across adult-use cannabis, international medical markets, craft beverages, and wellness foods. The company's primary strengths include a diversified revenue mix, an established European medical footprint, and a large US craft beer distribution network. Its primary growth story relies on future international cannabis legalization and the optionality to scale THC-infused beverages in the US. However, investors face notable risks from persistent net losses, pricing pressures, and unpredictable regulatory timelines. The stock suits risk-tolerant growth or momentum investors seeking exposure to legislative catalysts, and stakeholders should closely monitor regulatory reforms and profitability milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While top-line scale has expanded through acquisitions, consistent organic growth and profitability remain challenging. |
| Momentum investor | Strong fit while signal remains positive | The stock historically experiences sharp price rallies driven by legislative headlines and macro cannabis sentiment shifts. |
| Value investor | Weak fit | Ongoing net losses and balance sheet dilution make traditional valuation metrics difficult to justify for fundamental value strategies. |
| Dividend investor | Weak fit | Tilray does not pay dividends, retaining capital for corporate restructuring and market expansion. |
| Low-risk investor | Weak fit | High share price volatility and regulatory uncertainties expose investors to substantial downside risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is highly sensitive to legislative news cycles and speculative trading behavior. |
| Valuation risk | Medium / high | Unpredictable earnings timelines complicate traditional valuation assessments. |
| Competition risk (cannabis and craft beverage oversupply) | High | Intense market competition compresses profit margins across both core sectors. |
| Business quality | Medium | Diversification into craft beverages provides steady revenue, but cannabis operations face structural headwinds. |
| Dividend income | Low / none | No payouts are distributed to shareholders. |
| Execution risk | High | Successfully integrating multi-industry acquisitions and navigating international regulations requires flawless management execution. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 359.12M USD | Price to earnings Ratio - | 1Y Target Price 5.72 |
Price to earnings Ratio - | 1Y Target Price 5.72 | ||
Volume (30-day avg) 4.7M shares | Beta 2.06 | 52 Weeks Range 2.41 - 15.70 | Updated Date 11/14/2026 |
52 Weeks Range 2.41 - 15.70 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.37 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.7%
- Active BUY / eligible
- 69 / 110
- 30-Day BUY Count Change
- +30
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Drug Manufacturers - Specialty & Generic
- BUY participation
- 66.7%
- Active BUY / eligible
- 8 / 12
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -50.86% | Avg. Invested days 15 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Cannabis Segment | Sales of medical and adult-use cannabis flower, extracts, and derivatives across Canada, Europe, and international export channels. | This is the core business tied to long-term global legalization themes, though currently operating in a highly competitive environment. |
| Beverage Alcohol Segment | Production and wholesale distribution of craft beers, ciders, spirits, and ready-to-drink cocktails via acquired US craft breweries. | Provides immediate, tangible cash flow and establishes a ready-made distribution framework for potential future THC-infused drinks. |
| Wellness & Hemp Foods Segment | Sales of branded hemp food products, protein powders, and natural snacks primarily through Manitoba Harvest. | Offers stable consumer packaged goods revenue centered on health and wellness trends. |
| Geographic Distribution | Operations spanning Canada, the United States, and key European medical markets like Germany. | International exposure cushions the company against domestic regulatory delays in any single market. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 1000 | Enterprise Value 513.04M | Price to Sales(TTM) 0.37 |
Enterprise Value 513.04M | Price to Sales(TTM) 0.37 | ||
Enterprise Value to Revenue 0.53 | Enterprise Value to EBITDA 75.76 | Shares Outstanding 147.79M | Shares Floating 144.36M |
Shares Outstanding 147.79M | Shares Floating 144.36M | ||
Percent Insiders 2.38 | Percent Institutions 10.19 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

